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Signs and Symptoms

Introduction
Heart failure (HF) is a complex disease
that requires a high-level understanding
of pathophysiology and physics. The
basic idea behind HF is an inadequate
flow of oxygenated blood forward due to
failure of the heart to pump effectively.
As the disease progresses to an advanced
stage it can be increasingly devastating to
patients’ activities of daily living.
Advanced stage hart failure is defined
by Severino et al. as un unstable
condition that no longer responds to
standard treatment (2019). Treating end
stage heart failure can be both complex
yet common in the intensive care so it’s
important for nurses to understand the
pathophysiology of the disease. Death
often accompanies this disease without
early interventions to decrease
symptoms and prolong a patient’s life
span.
Heart failure has been significantly
studied but is a difficult topic for
students to understand. With increasing
number of admissions nurses need a
deeper understanding of the disease
process.
•

•

•

Heart failure accounts for an
abundance of hospital admissions
and mortality yearly; however, as
heart failure treatments continue
to advance, incidence of death
continues to decline (Gummert et
al., 2019)
The late stages of heart failure can
require decisions about quality of
life (Servino et al., 2019)
The end-result of the disease, when
medication alone don’t work is a
heart transplant, ventricular assist
device, or palliative care (Servino et
al, 2019)

(Heart Failure, 2017)

Many of the signs and symptoms are related to a backup of blood flow from
the corresponding side of the heart. The right side is specifically related to fluid
overload into the body while left sided creates fluid buildup into the lungs.
Theses systems are however interrelated and failure of one often results in
failure of the other. Bosch et al. resulted that while both HF with reduced EF and
HF with preserved EF led to right sided failure, the reduced EF group had a
worsened symptoms (2017).
•
•
•
•
•
•
•
•
•
•
•
•

Left Sided

Pulmonary congestion
Cough
Crackles
Wheezes
Tachypnea
Pink frothy sputum
Orthopnea
Tachycardia
Restlessness
Exertional dyspnea
Fatigue
Cyanosis
(Heart Failure, 2017)

•
•
•
•

•
•
•

(Heartfailure.jpg, 2018)

Testing

Vital signs to assess
hypotension, tachycardia,
tachypnea
EKG to assess ischemia and
ventricular hypertrophy
Right heart catherization to
measure heart chamber
pressure
Swan-Ganz Catheter for
continued measurement of
heart chamber pressure and
mixed venous blood gases
(Dunlay & Colucci, 2020)
Echocardiogram to assess size
and ejection fraction
Chest X-ray to assess lung
function
NT-pro BNP to assess fluid
overload and lactic acid level for
oxygen delivery
(wan et al., 2019)

Classification
New York Heart Association (NYHA)
Functional Classification
1.
No limitation of physical activity,
no fatigue, palpitation, or
dyspnea (I)
2.
Slight limitation of physical
activity, ordinary amount of
physical activity results in
fatigue, palpitation, dyspnea (II)
3.
Marked limitation of physical
activity, Less than ordinary
activity causes fatigue,
palpitation, or dyspnea (III)
4.
Unable to carry on any physical
activity without discomfort,
symptoms at rest (IV)

Pathophysiology
Left sided heart failure with reduced
ejection fraction (EF) is defined as an EF
< 40% with an inability of the heart to
produce a cardiac output that
adequately perfuses organs (Mccance
& Huether, 2018). When the left side
of the heart to doesn’t contract
properly a decrease cardiac output
occurs creating a back-up in
oxygenated blood flow. As the disease
worsens, organ systems begin to
suffer from lack of oxygen and the
body goes into cardiogenic shock.
Cardiac output is determined by the
volume of blood pumped out of the left
ventricle (stroke volume) multiplied by
a heart rate to determine the liters per
minute of blood flow (Mccance &
Huether, 2018). Cardiac output is
further determined by three key values,
preload, contractility, and afterload.
Preload is defined as the stretch or
length of left ventricular myocardial
fibers at end-diastole (Colucci & Cohn,
2020). Contractility is defined as the
force generated at any given preload
(Colucci & Cohn, 2020). Afterload is
defined as the impedance during
ejection (Colucci & Cohn, 2020).

The Pathophysiology of heart failure with
reduced EF is related to an impaired cardiac
contractile function. The most common cause of
this type of heart failure is a myocardial
infarction however myocarditis and
cardiomyopathies, increased myocardial
workload can all contribute (Mccance &
Huether, 2018). The result is a myocardium that
is unable push blood forward creating fluid to
backup and an increased preload. Nagelhout
mentioned that too much preload results in the
downslope of Frank-Starlings curve creating a
decrease in contractility due fluid overload
(2017). As cardiac output falls, the bodies
sensing receptors sense the changes and sets off
a cascade of events. Sympathetic output
attempts to restore cardiac output by increasing
the contractility and heart rate (Colucci & Cohn,
2020). The decreased flow to the kidneys
creates an increase in renin leading to the
cascade of the renin-angiotensin-aldosterone
and an increase in sodium, water, and blood
pressure (Nagelhout et al., 2017). These
mechanisms further worsen preload and
increase afterload. The heart then begins to
compensate by allowing hypertrophy of the
myocytes that innervates the left ventricle
(Colucci & Cohn, 2020). The Law of Laplace
describes wall thickness being indirectly related
to wall stress therefore increasing the size of the
muscle decreases the stress placed on the heart
to overcome afterload. This unfortunately
decreases the amount of blood that can fit
inside the ventricle further complicating the CO.

Heart Failure Cascade

Preload reduction
•
Diuretic therapy (Loop diuretics,
thiazides, mineralocorticoid
receptor antagonists) – Decreases
total body fluid (Dunlay & Colucci,
2020)
Afterload Reduction
•
Angiotensin receptor-neprilysin
inhibitor (ARNI), angiotensin
converting enzyme (ACE) inhibitor
or angiotensin receptor blocker
(ARBs) – One of these agents used
at a time to slow the remodeling of
the left ventricle and improve
survival (Meyer, 2020) – Should
titrate to higher doses if tolerated
for a reduction in worsening of
heart failure (Turgeon et al., 2019)
•
Beta-blocker – only after patient
condition has stabilized – start low
and titrate up to improve filling
time and decrease afterload
(Meyer, 2020)
•
Hydralazine plus Nitrates – used to
decrease resistance to flow, shown
to provide symptomatic and
mortality benefit (Meyer, 2020)
•
Nitrates – Reduction in afterload
(Dunlay & Colucci, 2020)
Contractility improvement
•
Inotropes – dobutamine or
milrinone – Increases squeeze on
heart and heart rate while also
decreasing afterload by lowering
blood pressure - should only be
used in acute decompensated HF
(Dunlay & Colucci)

Physics

Frank-Starling’s curve, Ohm’s, Poiseulle’s, and Laplace’s laws are all used to describe
contractility, flow, and resistance and remodeling of the ventricle. Ohm’s law defined by
Nagelhout is the correlation of flow of electricity between electrical pressure and
resistance to the flow (2017). Nagelhout defined Poiseulle’s law as the amount of fluid
flowing through a tube in relation to pressure across the tube, the radius, length, and
viscosity (2017). Ohm’s equation is rewritten in applied physics to demonstrated that the
flow (CO) is directly related to a pressure difference and inversely related to resistance.
Poiseuille’s law demonstrated that the largest impact on resistance to flow is the radius of
the tube. When applied to the body, doubling the radius has a 16-fold increase in flow. This
mechanism directly relates to the afterload the heart must overcome to pump blood
forward. Nagelhout described Frank-Starlings mechanism as an increase in left ventricle
preload that will increase contractility due to the stretch of the myocardium but only to a
certain extent (2017). Nagelhout described the Law of Laplace as the relationship of wall
tension to pressure and radius in cylinders (2017). This law comes into play when
understanding the mechanisms that create ventricular remodeling of the left ventricle
myocyte. Understanding the pressure-volume relationship is important to understand the
pathophysiology of heart failure.

•
•

•

•

•

Fluid restriction of 1.5 to 2.0 L/day
(Dunlay & Colucci, 2020)
Impella/Balloon pump/ECMO –
used as acute management of heart
failure in an ICU setting to improve
CO (Dunlay & Colucci, 2020)
Left Ventricular Assist Device
(LVAD) – used to improve quality
of life for those who are unable to
receive transplant or as a bridge in
those on the transplant list
Heart Transplant – gold standard to
fix heart failure, improved survival
and quality of life (Dunaly &
Colucci, 2020)
Palliative Care – beneficial for those
who already have diffuse end organ
damage and unable to benefit from
advanced therapies (Serverino et
al., 2019)

•
•
•
•
•

•

(McCance & Huether, 2018, Figure 32-38)

•

•

•

•

•

Relationship of pressure to output
•

•

•
(Nagelhout et al., 2017, Figure 25.20)

Nursing Implications
•

(Heart Failure, 2017)

Conclusion

Treatments

Medications

Nurses are first line caregivers and therefore recognize changes in patients prior
to others. Heart failure can decompensate quickly, the nurse's job is to recognize
the signs and symptoms and call the appropriate provider as soon as possible to
decrease ischemia to other organs and increase survival chance of the patient.
Understanding the concepts of preload, contractility, and afterload as well as
how each medication affects the heart can lead to better patient care.
Nurses need an in-depth hemodynamic understanding to titrate medications
based on Swan-Ganz catheter therapy.
Specialized treatments continue to advance such as Impella and LVAD, nursing
education needs to advance with it.
Heart failure can be complicated to treat, it takes an interdisciplinary approach.
Some institutions have specialized Heart Failure teams. Advocate for the use of
those doctors to manage the heart failure regimen.
Palliative care should be implemented early in the hospital course of heart
failure and work with the nurse to help patients determine their best treatment
route (Dunlay & Colucci).
Educating patients about the disease process, medications, treatments, and
lifestyle changes are an important part of the nursing profession to decrease
readmissions.

Heart failure is never going to be
eradicated; however, the current
understanding of the disease
process, prescribed treatments,
and interventions need to continue
to improve to save more lives
As the population continues to
grow older, more instances of heart
failure will occur
A deep understanding of physics
and pathophysiology can help a
nurse prevent adverse effects of
the disease process and
medications involved
The pathophysiology includes an
initial sympathetic and hormonal
response, over-use of these
maneuvers leads to cardiac
remodeling, decreased cardiac
output, and eventually failure to
compensate for demand (Wan et
al., 2019)
Sacubitril-valsartan (Entresto) –
ARNI has shown to reduce
mortality and hospitalizations
compared with the proven dose of
ACE inhibitors (Meyer, 2020)
A LVAD can improve quality of life
and increase lifespan compared to
standard therapy treatment of end
stage heart failure, however they
do have adverse risks (Gummert et
al., 2019)
Heart transplant is the gold
standard for treatment (Gummert
el al., 2019)
Palliative care can be beneficial for
those patients whose
pathophysiology is too
compromised throughout the body
to reverse (Serverino et al. 2019).
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